Prognostic improvement and treatment of COVID-19 in patients with rheumatic diseases until December 2022: Analysis of the JCR COVID-19 registry in Japan.

Yusuke KashiwadoYasutaka KimotoKenji OkuMari YamamotoShiro OhshimaSatoshi ItoTakahiko HoriuchiTsutomu Takeuchi

Published in: Modern rheumatology (2023)

COVID-19 prognosis improved over time in patients with rheumatic diseases, especially in the Omicron BA.5-dominant period. In the future, treatment of mild cases should be optimised.

Keyphrases

coronavirus disease
sars cov
respiratory syndrome coronavirus
combination therapy